CHPA Questions Timetable, Export Requirements In FDA’s NDC Proposal
This article was originally published in The Tan Sheet
Executive Summary
An FDA proposed rule for changes to the National Drug Code system does not adequately distinguish regulatory requirements for export-only and imported-for-export products, the Consumer Health Products Association says Jan. 26
You may also be interested in...
FDA Listing Proposed Rule Would Add Burdens To Code System – Industry
If FDA starts assigning companies National Drug Code numbers as it has proposed, it would "undo needed flexibility" for industry, the Consumer Healthcare Products Association says
FDA To Hold Drug Code Meeting, Extends Proposed Rule Comment Deadline
FDA has planned a public meeting to discuss proposed changes to the National Drug Code (NDC) system in the agency's proposed rule on "Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs," according to a notice published in the Oct. 31 Federal Register
Paperless Drug Code System Will Allow OTC Listings On DailyMed
FDA's proposed electronic listing system for national drug codes will help the agency expand its electronic labeling system to include OTC drugs, among other products